Inventor
WEBER DAVID A
US25 patents
⚠️ This page may combine multiple inventors who share the name “WEBER DAVID A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
12 patentsUS8911768B2Dec 16, 2014
Methods for treating retinopathy with extended therapeutic effect
ALLERGAN INC88 citations98
US7090681B2Aug 15, 2006
Methods and apparatus for delivery of ocular implants
ALLERGAN INC213 citations97
US8034370B2Oct 11, 2011
Ocular implant made by a double extrusion process
ALLERGAN INC32 citations96
US8034366B2Oct 11, 2011
Ocular implant made by a double extrusion process
ALLERGAN INC32 citations96
US7468065B2Dec 23, 2008
Apparatus for delivery of ocular implants
ALLERGAN INC116 citations95
US9192511B2Nov 24, 2015
Ocular implant made by a double extrusion process
ALLERGAN INC10 citations92
US8048445B2Nov 1, 2011
Ocular implant made by a double extrusion process
ALLERGAN INC14 citations92
US10702539B2Jul 7, 2020
Ocular implant made by a double extrusion process
ALLERGAN INC3 citations84
US10076526B2Sep 18, 2018
Ocular implant made by a double extrusion process
ALLERGAN INC6 citations84
US8802129B2Aug 12, 2014
Methods for treating retinopathy with extended therapeutic effect
ALLERGAN INC7 citations84
US9233071B2Jan 12, 2016
Methods for treating retinopathy with extended therapeutic effect
ALLERGAN INC0 citations52
US8778381B2Jul 15, 2014
Ocular implant made by a double extrusion process
ALLERGAN INC0 citations52
SANTEN PHARMACEUTICAL CO LTD
5 patentsUS8367097B2Feb 5, 2013
Liquid formulations for treatment of diseases or conditions
SANTEN PHARMACEUTICAL CO LTD31 citations95
US8927005B2Jan 6, 2015
Liquid formulations for treatment of diseases or conditions
SANTEN PHARMACEUTICAL CO LTD20 citations92
US9387165B2Jul 12, 2016
Rapamycin formulations and methods of their use
SANTEN PHARMACEUTICAL CO LTD3 citations72
US9381153B2Jul 5, 2016
Liquid formulations for treatment of diseases or conditions
SANTEN PHARMACEUTICAL CO LTD1 citations62
US9452156B2Sep 27, 2016
Formulations and methods for vascular permeability-related diseases or conditions
SANTEN PHARMACEUTICAL CO LTD0 citations51